Galina Gencheva

Dr. Galina Gencheva

Sofia University "St. Kliment Ohridski" Faculty of Chemistry and Pharmacy

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Bioinorganic Chemistry and Applications
Verified
Journal Article
Open access
PDF file
GMGeorgi Momekov
Georgi Momekov
DFDilyan Ferdinandov
Dilyan Ferdinandov
SKSpiro Konstantinov
Spiro Konstantinov
SASonja Arpadjan
Sonja Arpadjan
DTDaniela Tsekova
Daniela Tsekova
MKMargarita Karaivanova
Margarita Karaivanova
The antineoplastic potential of a stable monomeric Au(II) complex with hematoporphyrin IX (Hp), namely [Au(II)Hp-2H.], was investigated in a panel of tumor cell lines. The complex exhibits strong cytotoxicity, whereby the leukaemia‐ and lymphoma‐derived cell lines are more sensitive, with IC50 values comparable to those of the reference anticancer drug cisplatin. In contrast, the solid tumor models are more sensitive to the platinum drug. A comparative assessment of both agents against the human kidney cell line 293T has shown that [Au(II)Hp-2H.] is less cytotoxic. The gold complex induces oligonucleosomal DNA fragmentation in tumour cells following 24‐hour treatment and hence its cytotoxic effect is at least partly mediated by induction of apoptotic cell death. A prominent intracellular gold accumulation was detected after treating tumor cells with [Au(II)Hp-2H.] which shows that its putative pharmacological targets are readily accessible after a short incubation period.

1 January 2007 in Metal-Based Drugs
Verified
Journal Article
Open access
PDF file
GGGalina Gencheva
Galina Gencheva
DTD. Tsekova
D. Tsekova
GGG. Gochev
G. Gochev
GMGeorgi Momekov
Georgi Momekov
GTG. Tyuliev
G. Tyuliev
PBP. R. Bontchev
P. R. Bontchev
Three novel stable Pt(III) complexes with distorted octahedral structure and ground state have been obtained in the course of Pt(II)‐hematoporphyrin IX ((7,12‐bis(1‐hydroxyethyl)‐3,8,13,17‐tetramethyl‐21H‐23H‐porphyn‐2,18‐dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis‐[Pt(III)(Hp−3H)]⋅H2O1, [Pt(III)(Hp−3H)]⋅H2O2, and [Pt((O,O)Hp−2H)Cl] 3, were studied by UV‐Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis‐platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW‐3 cells (KE‐37 derivative) is due to induction of cell death through apoptosis.

Verified
Journal Article
Open access
PDF file
GMGeorgi Momekov
Georgi Momekov
Iva UgrinovaIva Ugrinova
Iva Ugrinova
EPEvdokia Pasheva
Evdokia Pasheva
DTDaniela Tsekova
Daniela Tsekova
GGGalina Gencheva
Galina Gencheva
Two paramagnetic PdIII complexes of hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp), namely a dinuclear one [PdIII2(Hp-3H)Cl3(H2O)5]·2PdCl2, Pd1 and a mononuclear metalloporphyrin type [PdIII(Hp-2H)Cl(H2O)]·H2O, Pd2 have been synthesized reproducibly and isolated as neutral compounds at different reaction conditions. Their structure and solution stability have been assayed by UV/Vis and EPR spectroscopy. The compounds researched have shown in vitro cell growth inhibitory effects at micromolar concentration against a panel of human tumor cell lines. A DNA fragmentation test in the HL-60 cell line has indicated that Pd1 causes comparable proapoptotic effects with regard to cisplatin but at substantially higher concentrations. Pd1 and cisplatin form intra-strand guanine bis-adducts as the palladium complex is less capable of forming DNA adducts. This demonstrates its cisplatin-dissimilar pharmacological profile. The test for efficient removal of DNA-adducts by the NER synthesis after modification of pBS plasmids with either cisplatin or Pd1 has manifested that the lesions induced by cisplatin are far better recognized and repaired compared those of Pd1. The study on the recognition and binding of the HMGB-1 protein to cisplatin or Pd1 modified DNA probes have shown that HMG proteins are less involved in the palladium agent cytotoxicity.

27 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VVVyara Velcheva
Vyara Velcheva
KHKaspar Hegetschweiler
Kaspar Hegetschweiler
GMGeorgi Momekov
Georgi Momekov
SIStefka Ivanova
Stefka Ivanova
Angel UgrinovAngel Ugrinov
Angel Ugrinov
GGGalina Gencheva
Galina Gencheva
Metal complexes occupy a special place in the field of treatment and diagnostics. Their main advantages stem from the possibility of fine-tuning their thermodynamic properties and kinetic behavior in the biological milieu by applying different approaches such as properly constructed inner coordination sphere, appropriate choice of ligands, metal oxidation state, redox potential, etc., which are specific to these compounds. Here we discuss the design and synthesis of two octahedral cationic Pt(IV) complexes of the tridentate ligand all-cis-2,4,6-triaminocyclohexane-1,3,5-triol (taci) with composition, fac-[Pt(taci)I3]+, 1 and bis-[Pt(taci)2]4+, 2 as well as the potential for their application as antineoplastic agents. The complexes have been isolated in a solid state as: fac-[Pt(taci)I3]I·3H2O (1A), fac-[Pt(taci)I3]I (1B), fac-[Pt(taci)I3]I·2DMF (1C), bis-[Pt(taci)2](CO3)2·6H2O (2A) by changing the acidity of the reaction systems, the molar ratios of the reagents and the counterions, and by re-crystallization. The ligand taci is coordinated through the NH2-groups, each molecule occupying three coordination places in the inner coordination sphere of Pt(IV). Monitoring of the hydrolysis processes of 1A and 2A at different acidity showed that while 2A remained stable over the study period, the I−-ions in 1A were successively substituted, with the main product under physiologically mimetic conditions being fac,cis-[Pt(taci)I(OH)2]+ (h2). The antiproliferative tests involved eight cancer cell models, among which chemosensitive (derived from leukemias and solid tumors) and chemoresistant human Acute myeloid leukemia lines (HL-60/Dox, HL-60/CDDP), as well as the non-malignant kidney’ cells HEK-293T showed that the complexes 1A and 2A are characterized by a fundamentally different profile of chemosensitivity and spectrum of cytotoxic activity compared to cisplatin. The new Pt(IV) complexes were shown to be more effective in selectively inhibiting the proliferation of human malignant cells compared to cisplatin. Remarkable activity was recorded for 1A, which showed an effect (IC50 = 8.9 ± 2.4) at more than 16-fold lower concentration than cisplatin (IC50 = 144.4 ± 9.8) against the resistant cell line HL-60/CDDP. In parallel, 1A exhibited virtually the same cytotoxic effect against the parental HL-60 cells (IC50 = 9.0 ± 1.2), where cisplatin displays comparable chemosensitivity (IC50 = 8.3 ± 0.8). The determined resistance indices (RI~1) show unequivocally that the resistant lines are sensitive to both compounds tested; therefore, they are capable of overcoming the mechanisms of cisplatin resistance. The structural features of these compounds and their promising pharmacological properties justify their inclusion in the group of “non-classical metal-based antitumor compounds” and are a prerequisite for the admission of alternative mechanisms of action.

29 July 2021 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
VVVyara Velcheva
Vyara Velcheva
KHKaspar Hegetschweiler
Kaspar Hegetschweiler
GGGalina Gencheva
Galina Gencheva
C6H18ClN3O7S, trigonal, P31c (no. 159), a = 8.3990(14) Å, b = 8.3990(14)∘, c = 9.6208(17) Å, V = 587.76(17) Å3, Z = 2, R gt (F) = 0.0497, wR ref (F 2) = 0.1404, T = 300.15 K.